Medicare spending reached $744 billion in 2022, up from $200 billion in 2000, representing an average annual growth rate of 6.3%, according to a recent KFF report. “Growth in total Medicare spending ...

The annual enrollment period for Medicare — government-supported health benefits for retirees — starts Oct. 15.

The vast majority of Medicare's top-selling brand-name oncology drugs in 2022 provided high added therapeutic benefit. Ten drugs were classified as low or no added therapeutic benefit compared with ...

The share of fee-for-service Medicare enrollees choosing a Medicare Supplement plan rose to 41.4% in 2022, increasing for the fifth consecutive year, according to findings from a new AHIP report. The ...

The 2022 Inflation Reduction Act allows Medicare to negotiate drug prices and cap out-of-pocket costs, lowering costs for older Americans. The law does not cut any benefits for Medicare recipients.

Spending on GLP-1 drugs under the Medicare Part D program has increased dramatically in recent years, and the annual cost of these drugs in the United States – upwards of $11,000 at recent list prices ...

Medicare Advantage plans are popular. They’re estimated by the Kaiser Family Foundation to have enrolled more than half of Medicare beneficiaries for the first time in 2024. But changes are underway.

A new review of tax forms released by the American Hospital Association (AHA) suggests nonprofit hospitals and health systems increased their collective total community benefit by $49 billion—nearly ...

(An earlier version of this post said that Paul Ryan’s plan for post-2022 Medicare spending would be indexed to GDP. In fact, it would be indexed to inflation. The earlier post also implied that ...

Medicare’s drug benefit, known as Part D, will see major changes next year as part of a broader push to help the 50 million-plus Americans enrolled in the program manage the cost of medicines. It’s ...